A Phase 2, Multiple-Dose Study of The Efficacy and Safety of Wafermine (Sublingual Ketamine) in Participants Experiencing Acute Post-Operative Bunionectomy or Abdominoplasty Pain
Latest Information Update: 27 May 2019
Price :
$35 *
At a glance
- Drugs Ketamine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors iX Biopharma
- 21 May 2019 According to an iX Biopharma media release, the U.S. Food and Drug Administration (FDA) has scheduled the End-of-Phase 2 (EOP2) meeting with the Company in the third quarter of 2019.
- 05 Sep 2018 According to an iX Biopharma media release, data from this trial will be presented at the BioEurope conference (Nov 2018).
- 05 Sep 2018 Results presented in the iX Biopharma media release.